In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair

The clinical use of human bone marrow–derived mesenchymal stem cells (BM-MSCs) has been hampered by their poor performance after transplantation into failing hearts. Here, to improve the therapeutic potential of BM-MSCs, we developed a strategy termed in vivo priming in which BM-MSCs are primed in v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Adv
Main Authors: Park, Bong-Woo, Jung, Soo-Hyun, Das, Sanskrita, Lee, Soon Min, Park, Jae-Hyun, Kim, Hyeok, Hwang, Ji-Won, Lee, Sunghun, Kim, Hyo-Jin, Kim, Hey-Yon, Jung, Seungman, Cho, Dong-Woo, Jang, Jinah, Ban, Kiwon, Park, Hun-Jun
Formato: Artigo
Idioma:Inglês
Publicado em: American Association for the Advancement of Science 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141892/
https://ncbi.nlm.nih.gov/pubmed/32284967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aay6994
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados